Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
          • CER Template sections
            • 00 Front matter, introduction, writing tips
            • 1. Administrative particulars
            • 2. Executive summary
            • 3. Scope of the clinical evaluation
            • 4. Clinical evaluation plan — Summary
            • 5. Common specifications and harmonised standards
            • 6. Clinical background, current knowledge, state of the art
            • 7. Equivalence
            • 8. Clinical evidence review
            • 9. Clinical evidence analysis — GSPRs
            • 10. Clinical evidence analysis — Benefit-risk profile
            • 15. Vendor services annex (non-normative)
            • 11–14. Conclusions, Author CVs, References, Excluded sources
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)
  • CER Template sections
  • 3. Scope of the clinical evaluation

3. Scope of the clinical evaluation

Source: CER Template.pdf pages 9-10 (document: Mantra Systems Free CER Template, Edition 2)

3.1 Objective​

State an objective for the Clinical Evaluation, e.g.:

  • Establish conformity of the device with relevant General Safety and Performance Requirements
  • Establish suitability for intended purpose
  • Establish acceptability of benefit-risk profile

3.2 Hypothesis​

The purpose of the hypothesis is to provide a scientific structure to the CER. Stating a hypothesis at the start of the CER enables it to be tested through appraisal and analysis of clinical evidence that follows.

It is sensible to structure the hypothesis around non-inferiority to comparable alternatives.

3.3 Device overview​

3.3.1 General description of the device​

Provide a full description of the medical device.

3.3.2 Device components​

Describe the composition of the device. What materials is the device made from? Does the device incorporate any medicinal substances, tissues or blood products?

3.3.3 Principles of use​

How is the device used in practice?

3.4 Device classification​

Why is the subject device a medical device according to the definition in Article 2 MDR?

What regulatory class is the device? Provide justification by directly quoting the (relevant) rules in Annex VIII MDR. Get further guidance on working with MDR Annex VIII.

3.5 Manufacturer and sales history​

State the name of the manufacturer, their address, and explain their experience in this field. State whether the manufacturer has any relevant credentials (e.g. ISO 13485-based quality system).

When was the device first CE-marked? In which countries/territories is the device sold? How many units have been sold to date?

3.6 Intended purpose & claims​

What is the intended purpose of the device? What claims does the manufacturer make?

3.7 Indications, contraindications and precautions​

What are the medical indications and contraindications for use of the device? What precautions and warnings are provided?

3.8 Target population and medical conditions​

What is the target disease or condition?

3.9 Accessories or compatible devices​

Describe any accessories associated with the device, and any compatible devices that it is designed to interface with.

3.10 Similar devices​

Give an overview of any similar devices that have been identified (whether in EU or in other territories).

Previous
2. Executive summary
Next
4. Clinical evaluation plan — Summary
  • 3.1 Objective
  • 3.2 Hypothesis
  • 3.3 Device overview
    • 3.3.1 General description of the device
    • 3.3.2 Device components
    • 3.3.3 Principles of use
  • 3.4 Device classification
  • 3.5 Manufacturer and sales history
  • 3.6 Intended purpose & claims
  • 3.7 Indications, contraindications and precautions
  • 3.8 Target population and medical conditions
  • 3.9 Accessories or compatible devices
  • 3.10 Similar devices
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)